Game-Changing Cancer Tech Nears FDA Completion (ad) |
In the world of tech advancements, a new player could outshine even AI. It's a revolutionary technology with the aim of transforming cancer detection. Imagine the leap from basic reading glasses to cutting-edge VR; that's the scale of innovation we're talking about. FDA review is in its final stages and it could become the gold standard before we know it.
Explore Investment Opportunities in This Market Disruptor |
|
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (ad) |
|
Apple Inc. (AAPL) Amazon.com, Inc. (AMZN) Barker Minerals Ltd (BML) - No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today
Meta Platforms, Inc. (META) - COO Javier Olivan sold 490 shares of the firm's stock in a transaction on Friday, March 1st. The shares were sold at an average price of $492.13, for a total value of $241,143.70. Following the completion of the transaction, the chief operating officer now owns 10,519 shares of the company's stock, valued at $5,176,715.47. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
- (3/6) Facebook, Instagram, Messenger and Threads logins restored after widespread outage - News 12 Bronx (news.google.com)
- (3/6) 3 Magnificent 7 Stocks to Buy Before They Soar 50% (investorplace.com)
- (3/6) How Meta Platforms Dominates the Internet, Explained in 1 Chart. (fool.com)
- (3/6) Millionaire's Blueprint: 7 Must-Have Stocks for Your Road to Wealthy Town (investorplace.com)
- (3/6) Entravision Communications crashes after Facebook owner Meta cancels all ad partner deals (proactiveinvestors.com)
- (3/6) META Stock Analysis: 3 Reasons to Buy Meta Platforms Now (investorplace.com)
- (3/6) Meta fixes Instagram and Facebook's global outages (proactiveinvestors.co.uk)
- (3/5) 5 Buy-Rated Stocks Shattering 52-Week Highs (zacks.com)
- (3/5) Buckle Up, Buttercup! 7 Hypergrowth Tech Stocks Revving Their Engines (investorplace.com)
- (3/5) The EPA hails the arrest of California man accused of smuggling illicit air coolants into the US (marketbeat.com)
Microsoft Co. (MSFT) - Bloom Energy (NYSE:BE) was upgraded by analysts at Truist Financial Co. from a "sell" rating to a "hold" rating. They now have a $11.00 price target on the stock, up previously from $9.00. This represents a 13.4% upside from the current price of $9.70.
- Corbus Pharmaceuticals (NASDAQ:CRBP) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $46.00 price target on the stock, up previously from $4.00. This represents a 24.4% upside from the current price of $36.98.
- Airbus (OTCMKTS:EADSY) was upgraded by analysts at UBS Group AG from a "sell" rating to a "neutral" rating.The current price is $42.59.
- GitLab (NASDAQ:GTLB) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $75.00 price target on the stock. This represents a 21.7% upside from the current price of $61.65.
- Honeywell International (NASDAQ:HON) was upgraded by analysts at Berenberg Bank from a "hold" rating to a "buy" rating. They now have a $240.00 price target on the stock, up previously from $195.00. This represents a 19.1% upside from the current price of $201.46.
- International Consolidated Airlines Group (OTCMKTS:ICAGY) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to an "overweight" rating.The current price is $3.56.
- Progressive (NYSE:PGR) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $227.00 price target on the stock, up previously from $185.00. This represents a 17.5% upside from the current price of $193.17.
- REGENXBIO (NASDAQ:RGNX) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $37.00 price target on the stock. This represents a 50.6% upside from the current price of $24.57.
- Target (NYSE:TGT) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $206.00 price target on the stock, up previously from $149.00. This represents a 19.5% upside from the current price of $172.37.
- Target (NYSE:TGT) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $195.00 price target on the stock, up previously from $140.00. This represents a 13.1% upside from the current price of $172.37.
- View today's most recent analysts' upgrades at MarketBeat.com
Set aside 3 minutes now, and collect a monthly check for eternity (ad) |
If you set aside just 3 minutes, right now, you could set yourself up for a near eternal monthly income stream with this "forever dividend stock". I've done over 31 years of due diligence, and this is without a doubt, the most reliable dividend stock money can buy. It's a stream of income you can pass down to your kids, your grandkids.
Click here to claim your "eternal income" FREE report. |
|
4 dividend stocks paying you 4 checks every month (ad) |
My name is Tim Plahen. I'll show over 300,000 dividend investors how to find the very best dividend stocks every month. Normally, I'd charge up to $99 for this dividend report… but I'm giving it to you for free today as the markets are tough right now. Inside 4 Dividend Stocks Paying you 4X This Month, I'll reveal a way to collect a dividend every single week of the year.
Get the free report now. |
|
- Acadia Healthcare (NASDAQ:ACHC) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $100.00 price target on the stock. This represents a 17.5% upside from the current price of $85.11.
- Addus HomeCare (NASDAQ:ADUS) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $88.00 price target on the stock. This represents a 11.1% downside from the current price of $99.01.
- agilon health (NYSE:AGL) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $5.00 price target on the stock. This represents a 12.3% downside from the current price of $5.70.
- Alignment Healthcare (NASDAQ:ALHC) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $4.50 price target on the stock. This represents a 14.0% downside from the current price of $5.23.
- Aspen Aerogels (NYSE:ASPN) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $22.00 price target on the stock. This represents a 30.2% upside from the current price of $16.90.
- AST SpaceMobile (NASDAQ:ASTS) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $7.50 price target on the stock. This represents a 135.8% upside from the current price of $3.18.
- BrightSpring Health Services (NASDAQ:BTSG) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $13.00 price target on the stock. This represents a 39.5% upside from the current price of $9.32.
- Casey's General Stores (NASDAQ:CASY) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $345.00 price target on the stock. This represents a 14.9% upside from the current price of $300.39.
- The Cigna Group (NYSE:CI) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $393.00 price target on the stock. This represents a 16.0% upside from the current price of $338.74.
- Centene (NYSE:CNC) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $101.00 price target on the stock. This represents a 30.1% upside from the current price of $77.65.
- Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $68.00 price target on the stock. This represents a 54.5% upside from the current price of $44.00.
- CVS Health (NYSE:CVS) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $78.00 price target on the stock. This represents a 4.9% upside from the current price of $74.34.
- Community Health Systems (NYSE:CYH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $3.00 price target on the stock. This represents a 6.8% upside from the current price of $2.81.
- DaVita (NYSE:DVA) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $133.00 price target on the stock. This represents a 0.7% upside from the current price of $132.01.
- Encompass Health (NYSE:EHC) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $95.00 price target on the stock. This represents a 24.8% upside from the current price of $76.14.
- Elevance Health (NYSE:ELV) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $584.00 price target on the stock. This represents a 15.6% upside from the current price of $505.21.
- Electrovaya (NASDAQ:ELVA) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $8.00 price target on the stock. This represents a 100.0% upside from the current price of $4.00.
- Flux Power (NASDAQ:FLUX) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $10.00 price target on the stock. This represents a 130.4% upside from the current price of $4.34.
- Fortrea (NASDAQ:FTRE) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $36.00 price target on the stock. This represents a 2.2% downside from the current price of $36.81.
- HCA Healthcare (NYSE:HCA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $356.00 price target on the stock. This represents a 10.5% upside from the current price of $322.12.
- Humana (NYSE:HUM) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $356.00 price target on the stock. This represents a 4.5% upside from the current price of $340.74.
- Madrigal Pharmaceuticals (NASDAQ:MDGL) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $382.00 price target on the stock. This represents a 41.9% upside from the current price of $269.23.
- Monster Beverage (NASDAQ:MNST) is now covered by analysts at Redburn Atlantic. They set a "buy" rating on the stock.The current price is $57.99.
- Molina Healthcare (NYSE:MOH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $437.00 price target on the stock. This represents a 12.5% upside from the current price of $388.55.
- NVIDIA (NASDAQ:NVDA) is now covered by analysts at CICC Research. They set an "outperform" rating and a $870.00 price target on the stock. This represents a 1.7% downside from the current price of $884.60.
- Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $22.00 price target on the stock. This represents a 3.8% upside from the current price of $21.19.
- Pure Storage (NYSE:PSTG) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $66.00 price target on the stock. This represents a 14.9% upside from the current price of $57.44.
- RadNet (NASDAQ:RDNT) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $48.00 price target on the stock. This represents a 1.4% upside from the current price of $47.34.
- Sanmina (NASDAQ:SANM) is now covered by analysts at Fox Advisors. They set an "overweight" rating and a $80.00 price target on the stock. This represents a 22.0% upside from the current price of $65.59.
- Surgery Partners (NASDAQ:SGRY) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $35.00 price target on the stock. This represents a 12.9% upside from the current price of $31.01.
- Super Micro Computer (NASDAQ:SMCI) is now covered by analysts at Argus. They set a "buy" rating and a $1,350.00 price target on the stock. This represents a 18.5% upside from the current price of $1,139.01.
- SolarWinds (NYSE:SWI) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $13.00 price target on the stock. This represents a 8.3% upside from the current price of $12.00.
- Stock Yards Bancorp (NASDAQ:SYBT) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $52.00 price target on the stock. This represents a 13.1% upside from the current price of $45.99.
- BBB Foods (NYSE:TBBB) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $30.00 price target on the stock. This represents a 35.4% upside from the current price of $22.15.
- Tenet Healthcare (NYSE:THC) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $113.00 price target on the stock. This represents a 15.9% upside from the current price of $97.47.
- Thermon Group (NYSE:THR) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $36.00 price target on the stock. This represents a 30.6% upside from the current price of $27.57.
- Universal Health Services (NYSE:UHS) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $181.00 price target on the stock. This represents a 2.4% upside from the current price of $176.73.
- UnitedHealth Group (NYSE:UNH) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $551.00 price target on the stock. This represents a 16.1% upside from the current price of $474.52.
- WisdomTree (NYSE:WT) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $12.00 price target on the stock. This represents a 47.1% upside from the current price of $8.16.
- View today's most recent analysts' new coverage at MarketBeat.com
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL |
|
Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW |
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: This is the #1 Stock to Buy for the AI Tidal Wave |
|
No comments:
Post a Comment